[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2115683T3 - Inmunoensayo indirecto para detectar compuestos de tipo dioxina. - Google Patents

Inmunoensayo indirecto para detectar compuestos de tipo dioxina.

Info

Publication number
ES2115683T3
ES2115683T3 ES92925178T ES92925178T ES2115683T3 ES 2115683 T3 ES2115683 T3 ES 2115683T3 ES 92925178 T ES92925178 T ES 92925178T ES 92925178 T ES92925178 T ES 92925178T ES 2115683 T3 ES2115683 T3 ES 2115683T3
Authority
ES
Spain
Prior art keywords
dioxin
type compounds
immuno assay
indirect immuno
phosphorilation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92925178T
Other languages
English (en)
Inventor
John G Babish
Sakina El-Tom
Xinfang Ma
Geoffrey Wheelock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of ES2115683T3 publication Critical patent/ES2115683T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/40—Dioxins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

ESTA INVENCION ES RELATIVA A LA DETERMINACION DE EXPOSICION EN VIVO A COMPUESTOS DE TIPO DIOXINA Y A LA CUANTIFICACION IN VITRO DE COMPUESTOS TIPO DIOXINA BASADOS EN LA FOSFORILACION DE TIROSINA DE PROTEINA INTERMEDIA POR EL RECEPTOR AH. LA AMPLITUD DE FOSFORILACION DE TIROSINA DE PROTEINA SE DETERMINA POR ANTICUERPOS MONOCLONALES PARA EL FOSFATO DE TIROSINA DE LA PROTEINA. LA CANTIDAD Y NATURALEZA DE TIROSILFOSFATOS DE LA PROTEINA ESTA CUANTITATIVAMENTE RELACIONADA A LA CONCENTRACION EN VIVO O IN VITRO DE DIOXINA A LA CUAL ESTAN EXPUESTOS CELULAS O ANIMALES. ESTE METODO PERMITE DETECCION DE COMPUESTOS DE TIPO DIOXINA A CONCENTRACIONES EN EL RANGO DE PARTES POR BILLON Y PARTES POR MIL MILLONES.
ES92925178T 1991-11-15 1992-11-13 Inmunoensayo indirecto para detectar compuestos de tipo dioxina. Expired - Lifetime ES2115683T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79292291A 1991-11-15 1991-11-15
US79519391A 1991-11-19 1991-11-19

Publications (1)

Publication Number Publication Date
ES2115683T3 true ES2115683T3 (es) 1998-07-01

Family

ID=27121346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92925178T Expired - Lifetime ES2115683T3 (es) 1991-11-15 1992-11-13 Inmunoensayo indirecto para detectar compuestos de tipo dioxina.

Country Status (7)

Country Link
US (2) US5529899A (es)
EP (1) EP0614530B1 (es)
JP (1) JP3253300B2 (es)
DE (1) DE69224651T2 (es)
DK (1) DK0614530T3 (es)
ES (1) ES2115683T3 (es)
WO (1) WO1993010460A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127136A (en) * 1995-10-23 2000-10-03 Paracelsian, Inc. Detection of dioxin-like compounds by detection of transformed Ah receptor/ARNT complex
US5800784A (en) * 1996-07-09 1998-09-01 Horn; Marcus J. Chemical sample treatment system and cassette, and methods for effecting multistep treatment process
ES2302349T3 (es) 1997-03-07 2008-07-01 Disc-O-Tech Medical Technologies, Ltd. Sistemas para la estabilizacion, fijacion y reparacion osea y vertebral percutaneas.
US5854010A (en) * 1997-03-10 1998-12-29 Denison; Michael S. Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor
US20030044856A1 (en) * 1997-09-26 2003-03-06 Puschett Jules B. Method of determining volume dependent hypertension through protein reduction in phosphorylation or concentration and related apparatus
WO1999045390A1 (en) * 1998-03-03 1999-09-10 Frank Comhaire Composition and device for the detection and elimination of endocrine hormones and/or hormone disrupting substances in and from fluids
DE19811327A1 (de) * 1998-03-16 1999-09-30 Karlsruhe Forschzent Verfahren zur Bestimmung von chemischen Verbindungen
US6780596B2 (en) * 1998-09-17 2004-08-24 Ashni Naturaceuticals, Inc. Methods for determining the activity of complex mixtures
WO2000026404A1 (en) * 1998-10-30 2000-05-11 Takara Shuzo Co., Ltd. Method for detecting gene affected by endocrine disruptor
US6309828B1 (en) 1998-11-18 2001-10-30 Agilent Technologies, Inc. Method and apparatus for fabricating replicate arrays of nucleic acid molecules
US20030003491A1 (en) * 2000-01-20 2003-01-02 Takashi Minegishi Method for detecting or quantifying environmental hormones
PT1265928E (pt) * 2000-01-27 2010-09-30 Medimmune Llc Anticorpos neutralizantes com afinidade ultra-elevada
EP2341074A1 (en) * 2000-03-01 2011-07-06 MedImmune, LLC Antibodies binding to the f protein of a respiratory syncytial virus (rsv)
US6855493B2 (en) * 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
EP1436598B1 (en) 2001-09-10 2013-11-27 Meso Scale Technologies LLC Assay buffer, compositions containing the same, and methods of using the same
US20040259096A1 (en) * 2001-11-02 2004-12-23 Allen Randy Leiman Receptor capture assay
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US20050244953A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Techniques for controlling the optical properties of assay devices
AU2005302453A1 (en) * 2004-10-29 2006-05-11 Medimmune, Llc Methods of preventing and treating RSV infections and related conditions
US20080237458A1 (en) * 2007-04-02 2008-10-02 Yongdong Wang Automated mass spectral identification
EP1997830A1 (en) * 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
US8877434B2 (en) 2012-04-19 2014-11-04 Hsinyu Lee Method and system of detecting dioxin-like compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238472A (en) * 1978-11-27 1980-12-09 United States Of America Radioimmunoassay for chlorinated dibenzo-p-dioxins
US4904595A (en) * 1985-06-14 1990-02-27 Health Research Incorporated Epithelial cell line useful in the detection of dioxinlike compounds and methods of making and using same
US4798807A (en) * 1986-06-24 1989-01-17 The Regents Of The University Of California Monoclonal antibodies and method for detecting dioxins and dibenzofurans
US4891322A (en) * 1987-02-24 1990-01-02 Mobil Oil Corporation Assaying of polynuclear aromatic compounds
NL8900529A (nl) * 1989-03-03 1990-10-01 Eurodiagnostics B V Werkwijze en kit voor het bepalen van tyrosine fosforylerende en defosforylerende activiteit.
US5262297A (en) * 1990-06-18 1993-11-16 Eastman Kodak Company Specific binding analytical and separation methods using carboxy containing polymers
IL102523A0 (en) * 1991-07-31 1993-01-14 Du Pont Enhancing the chemiluminescence of enzyme-triggered 1,2-dioxetanes

Also Published As

Publication number Publication date
US5496703A (en) 1996-03-05
EP0614530A1 (en) 1994-09-14
WO1993010460A1 (en) 1993-05-27
DE69224651D1 (de) 1998-04-09
JP3253300B2 (ja) 2002-02-04
EP0614530B1 (en) 1998-03-04
US5529899A (en) 1996-06-25
EP0614530A4 (en) 1995-06-07
DK0614530T3 (da) 1998-09-28
JPH07501883A (ja) 1995-02-23
DE69224651T2 (de) 1998-07-23

Similar Documents

Publication Publication Date Title
ES2115683T3 (es) Inmunoensayo indirecto para detectar compuestos de tipo dioxina.
Gillespie et al. Chemiluminescence detection of proteins from single cells.
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
Galgani et al. Interaction of environmental xenobiotics with a multixenobiotic defense mechanism in the bay mussel Mytilus galloprovincialis from the coast of California
ES2093017T3 (es) Anticuerpo contra el receptor de la interleuquina-6 humana.
FR2595817B1 (fr) Procede de determination de l'orientation d'une plate-forme de capteur imageur ou instrument analogue
PT848755E (pt) Proteina relacionada com o vegf
ES2171676T3 (es) Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.
DE3687490D1 (de) Remissionsmessgeraet zur beruehrungslosen messung.
DE69425709D1 (de) Zusammensetzung zur Kalibrierung oder Kontrolle zur Verwendung in einem serologischen IgM-Test
ES2133772T3 (es) Inmunoensayo para la homocisteina.
Giuliani et al. The P2X7 receptor is shed into circulation: correlation with C-reactive protein levels
MacKay et al. Protein changes associated with stages of activation of mouse macrophages for tumor cell killing.
Oldham Antibodies to Fasciola hepatica antigens during experimental infections in cattle measured by ELISA
ATE275728T1 (de) Verfahren und biosensor zum nachweis von antigenen
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
Müller-Felber et al. Myositis in Lyme borreliosis: an immunohistochemical study of seven patients
Gönenç et al. Comparison of crude and excretory/secretory antigens for the diagnosis of Fasciola hepatica in sheep by western blotting
ES2122292T3 (es) Diagnosis precoz de sepsis utilizando interacciones antigeno-anticuerpo amplificadas por quimioluminiscencia de sangre completa.
ES2523896T3 (es) Inmunoensayo de zolpidem con ventana de detección extendida
DK1423543T3 (da) Detektion af bovin virusdiarré-virus i vævspröver
KR930000539A (ko) 신규항 tcf-ii 모노클로날 항체 및 그것을 사용한 tcf-ii 측정방법
Schmitz et al. A comparative phylogenetic study of the distribution of cerebellar GABAA/benzodiazepine receptors using radioligands and monoclonal antibodies
CN104126122A (zh) 与胰岛素受体族反应抗体结合性能调节剂之识别
ITRM920603A1 (it) La sequenza dell'inserto cprl3, parte del gene della proteina della oociste di cryptosporidium (cowp), e derivati utili per la diagnosi dell'infezione da cryptosporidium

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 614530

Country of ref document: ES